Endomorphin 1 activates nitric oxide synthase 2 activity and downregulates nitric oxide synthase 2 mRNA expression

Neuroscience

Volumn 144, Issue 4, 2007, Pages 1454-1461

  Saric A ^a   Balog, T ^a   Sobocanec S ^a   Marotti, T ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

opioid receptor; amperometric detection; nitric oxide

Indexed keywords

BETA FUNALTREXAMINE; ENDOMORPHIN 1; ENDOMORPHIN 2; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; LIGAND; LIPOPOLYSACCHARIDE; MESSENGER RNA; MU OPIATE RECEPTOR; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OPIATE ANTAGONIST; OPIATE PEPTIDE;

AMPEROMETRY; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GRIESS METHOD; MACROPHAGE; MEASUREMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN STRUCTURE; TRANSCRIPTION INITIATION; VASODILATATION;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NARCOTIC ANTAGONISTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OLIGOPEPTIDES; RECEPTORS, OPIOID, MU; RNA, MESSENGER; UP-REGULATION;

EID: 33846299222     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.11.020     Document Type: Article

References (55)

1. Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci 75 (2004) 639-653
2. Azuma Y., and Ohura K. Endomorphin-2 modulates productions of TNF-alpha, IL-1beta, IL-10, and IL-12, and alters functions related to innate immune of macrophages. Inflammation 26 (2002) 223-232
3. Balog T., Marotti T., Musani V., Sobočanec S., and Šverko V. The effect of methionine-enkephalin on nitric oxide release in mice is age and gender related. Pharmacol Res 44 (2001) 287-292
4. Bengoechea-Alonso M.T., Pelacho B., Oses-Prieto J.A., Santiago E., Lopez-Moratalla N., and Lopez-Zabalza M.J. Regulation of NF-kappaB activation by protein phosphatase 2B and NO, via protein kinase A activity, in human monocytes. Nitric Oxide 8 (2003) 65-74
5. Bustamante S.A., Pang Y., Romero S., Pierce M.R., Voelker C.A., Thompson J.H., Sandoval M., Liu X., and Miller M.J. Inducible nitric oxide synthase and the regulation of central vessel caliber in the fetal rat. Circulation 94 (1996) 1948-1953
6. Champion H.C., Bivalacqua T.J., Friedman D.E., Zadina J.E., Kastin A.J., and Kadowitz P.J. Nitric oxide release mediates vasodilator responses to endomorphin 1 but not nociceptin/OFQ in the hindquarters vascular bed of the rat. Peptides 19 (1998) 1595-1602
7. Cho S.Y., Park S.J., Kwon M.J., Jeong T.S., Bok S.H., Choi W.Y., Jeong W.I., Ryu S.Y., Do S.H., Lee C.S., Song J.C., and Jeong K.S. Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem 243 (2003) 153-160
8. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
9. Colasanti M., Persichini T., Menegazzi M., Mariotto S., Giordano E., Caldarera C.M., Sogos V., Lauro G.M., and Suzuki H. Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J Biol Chem 270 (1995) 26731-26733
10. Eisenstein T.K., Hilburger M.E., and Lawrence D.M.P. Immunomodulation by morphine and other opioids. In: Friedman H., Klein T.W., and Specter S. (Eds). Drugs of abuse, immunity and infections (1996), CRC Press, Boca Raton 103-120
11. Gabrilovac J., Balog T., and Andreis A. Dynorphin-A(1-17) decreases nitric oxide release and cytotoxicity induced with lipopolysaccharide plus interferon-gamma in murine macrophage cell line J774. Biomed Pharmacother 57 (2003) 351-358
12. 15N) nitrate in biological fluids. Anal Biochem 126 (1982) 131-138
13. Hori T., Nakashima T., Take S., Kaizuka Y., Mori T., and Katafuchi T. Immune cytokines and regulation of body temperature, food intake and cellular immunity. Brain Res Bull 27 (1991) 309-313
14. Iuvone T., Capasso A., D Ǎcquisto F., and Carnuccio R. Opioids inhibit induction of nitric oxide synthase in J774 macrophages. Biochem Biophys Res Commun 212 (1995) 975-980
15. Jacobs A.T., and Ignarro L.J. Lipopolysaccharide-induced expression of interferon-beta mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages. J Biol Chem 276 (2001) 47950-47957
16. Jeanjean A.P., Moussaoui S.M., Maloteaux J.-M., and Laduron P.M. Interleukin-1β induces long term increase of axonally transported opiate receptors and substances P. Neuroscience 68 (1995) 151-157
17. Jessop D.S., Major G.N., Coventry T.L., Kaye S.J., Fulford A.J., Harbuz M.S., and De Bree F.M. Novel opioid peptides endomorphin-1 and endomorphin-2 are present in mammalian tissues. J Neuroimmunol 106 (2000) 53-59
18. Kalinowski L., Dobrucki L.W., Brovkovych V., and Malinski T. Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin. Circulation 105 (2002) 933-938
19. Kanjhan R. Opioids and pain. Clin Exp Pharmacol Physiol 22 (1995) 397-403
20. Korhonen R., Kankaanranta H., Lahti A., Lahde M., Knowles R.G., and Moilanen E. Bi-directional effects of the elevation of intracellular calcium on the expression of inducible nitric oxide synthase in J774 macrophages exposed to low and to high concentrations of endotoxin. Biochem J 354 (2001) 351-358
21. Korhonen R., Korpela R., and Moilanen E. Signalling mechanisms involved in the induction of inducible nitric oxide synthase by Lactobacillus rhamnosus GG, endotoxin, and lipoteichoic acid. Inflammation 26 (2002) 207-214
22. Kubes P., and Granger N.D. Nitric oxide modulates microvascular permeability. Am J Physiol 262 (1992) H611-H615
23. Lin X., Yang D.J., Cai W.Q., Zhao Q.Y., Gao Y.F., Chen Q., and Wang R. Endomorphins, endogenous opioid peptides, provide antioxidant defense in the brain against free radical-induced damage. Biochim Biophys Acta 1639 (2003) 195-202
24. Lortie M.J., Ishizuka S., Schwartz D., and Blantz R.C. Bioactive products of arginine in sepsis: tissue and plasma composition after LPS and iNOS blockade. Am J Physiol Cell Physiol 278 (2000) C1191-C1199
25. Magazine H.I., Liu Y., Bilfinger T.V., Fricchione G.L., and Stefano G.B. Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J Immunol 156 (1996) 4845-4850
26. Mariotto S., Cuzzolin L., Adami A., Del Soldato P., Suzuki H., and Benoni G. Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils. Br J Pharmacol 114 (1995) 1105-1106
27. Marotti T., Balog T., Mažuran R., and Ročić B. The role of cytokines in MET-enkephalin-modulated nitric oxide release. Neuropeptides 32 (1998) 57-62
28. Marotti T., Šverko V., and Hršak I. Modulation of superoxide anion release from human polymorphonuclear cells by Met- and Leu-enkephalin. Brain Behav Immunol 4 (1990) 13-22
29. Martin-Shild S., Gerall A.A., Kastin A.J., and Zadina J.E. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J Comp Neurol 405 (1999) 450-471
30. Moncada S., and Higgs A. The l-arginine nitric oxide pathway. N Engl J Med 329 (1993) 2002-2012
31. Moncada S., Palmer R.M., and Higgs A. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension 12 (1988) 365-372
32. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology pathophysiology, and pharmacology. Pharmacol Rev 43 (1991) 109-142
33. Nakaya M., Tachibana H., and Yamada K. Isoflavone genistein and daidzein up-regulate LPS-induced inducible nitric oxide synthase activity through estrogen receptor pathway in RAW264.7 cells. Biochem Pharmacol 71 (2005) 108-114
34. Niu X.F., Smith C.W., and Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 74 (1994) 1133-1140
35. Pan J., Burgher K.L., Szczepanik A.M., and Ringheim G.E. Tyrosine phosphorylation of inducible nitric oxide synthase: implications for potential post-translational regulation. Biochem J 314 (1996) 889-894
36. Péter A., Tóth G., Tömböly C., Laus G., and Tourwè D. Liquid chromatographic study of the enzymatic degradation of endomorphins, with identification by electrospray ionization mass spectrometry. J Chromatogr A 846 (1999) 39-48
37. Peterson P.K., Gekker G., Schut R., Hu S., Balfour Jr. H.H., and Chao C.C. Enhancement of HIV-1 replication by opiates and cocaine: The cytokine connection. In: Friedman H., Klein T., and Specter S. (Eds). Drugs of abuse, immunity and AIDS (1993), Plenum Press, New York 181-188
38. Peterson P.K., Molitor T.W., and Chao C.C. Mechanisms of morphine-induced immunomodulation. Biochem Pharmacol 46 (1993) 343-348
39. Roques B.P., Noble F., Dauge V., Fournie-Zaluski M.C., and Beaumont A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45 (1993) 87-146
40. Sakai K., Suzuki H., Oda H., Akaike T., Azuma Y., Murakami T., Sugi K., Ito T., Ichinose H., Koyasu S., and Shirai M. Phosphoinositide 3-kinase in nitric oxide synthesis in macrophage: critical dimerization of inducible nitric-oxide synthase. J Biol Chem 281 (2006) 17736-17742
41. Salh B., Wagey R., Marotta A., Tao J.S., and Pelech S. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002 and wortmannin on nitric oxide production. J Immunol 161 (1998) 6947-6954
42. Sharp B., and Linner K. What do we know about the expression of proopiomelanocortin transcripts and related peptides in lymphoid tissue?. Endocrinology 133 (1993) 1921A-1921B
43. Stefano G.B., Goumon Y., Bilfinger T.V., Welters I.D., and Cadet P. Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor. Prog Neurobiol 60 (2000) 513-530
44. Stefano G.B., Prevot V., Beauvillain J.C., Fimiani C., Welters I., Cadet P., Breton C., Pestel J., Salzet M., and Bilfinger T.V. Estradiol coupling to human monocyte nitric oxide release is dependent on intracellular calcium transients: evidence for an estrogen surface receptor. J Immunol 163 (1999) 3758-3763
45. Stefano G.B., Salzet M., Rialas C.M., Mattocks D., Fimiani C., and Bilfinger T.V. Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications. Int J Cardiol 64 (1998) s3-s13
46. Stefano G.B., Salzet M., Magazine H., and Bilfinger T.V. Antagonism of LPS and IFN-gamma induction of iNOS in human saphenous vein endothelium by morphine and anadamide by nitric oxide inhibition od adenylate cyclase. J Cardiovasc Pharm 31 (1998) 813-820
47. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med 332 (1995) 1685-1690
48. Stein C., Hassan A.H.S., Prezewlocki R., Gramsch C., Péter K., and Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci U S A 87 (1990) 5935-5939
49. Stolarek R., Kula P., Kurmanowska Z., and Nowak D. Effect of various agonists on nitric oxide generation by human polymorphonuclear leukocytes. Int J Clin Lab Res 28 (1998) 104-109
50. Šverko V., Sobočanec S., Balog T., and Marotti T. Met-enkephalin modulates lipid peroxidation and total sialic acid level in CBA mice in age- and sex-dependent manners. Exp Gerontol 37 (2002) 1413-1421
51. Vega R., and Soto E. Opioid receptors mediate a postsynaptic facilitation and a presynaptic inhibition at the afferent synapse of axolotl vestibular hair cells. Neuroscience 118 (2003) 75-85
52. Vujić V., Stanojević S., and Dimitrijević M. Methionine-enkephalin stimulates hydrogen peroxide and nitric oxide production in rat peritoneal macrophages: Interaction of μ, δ, and λ opioid receptors. Neuroimmunomodulation 11 (2004) 392-403
53. Xin L., and Blatteis C.M. Hypothalamic neuronal responses to interleukin-6 in tissue slices: Effects of indomethacin and naloxone. Brain Res Bull 29 (1992) 27-35
54. Zadina J.E., Hackler L., Ge L.-J., and Kastin A.J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386 (1997) 499-502
55. Zhang L., Gu Z.F., Pradhan T., Jensen R.T., and Maton P.N. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach. Am J Physiol Gastrointest Liver Physiol 262 (1992) G461-G469